Gland Pharma gets U.S. FDA nod for Sugammadex injection
FDA stamps approval | Photo Credit: Getty Images Shares of Gland Pharma were in the spotlight on Tuesday, rising more than 4%, after the Hyderabad-based generic injectable drugmaker got the U.S. Food and Drug Administration (FDA) approval for its abbreviated new drug application for Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL…
Read More “Gland Pharma gets U.S. FDA nod for Sugammadex injection” »